
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI (naloxone) and SYMJEPI. ZIMHI (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis
Dmk pharmaceuticals corporation operates in the Pharmaceutical manufacturing industry.
Dmk pharmaceuticals corporation's revenue is 11m - 100m
Dmk pharmaceuticals corporation has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.